-
NEWS
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision SurgeryLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial...
-
NEWS
Studies Confirm: New Fingertip Blood Collection Device Has Equivalent Testing Accuracy of Higher-Volume Draws from VeinLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX) and Babson Diagnostics today announced the results of new studies demonstrating that...
-
News
Patterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022Learn more